Risk Analysis
Welcome.
Sign in or register.
Refer A Friend
|
Contact Us
Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
Tracking 1053 U.S. listed China Stocks and Counting...
Tracking 1535 U.S. Stocks and Counting...
Home
Market Activity
Shell Activity
Research
Message Boards
GeoBlog
About
GeoResearch
GeoBargains
GeoSpecials
Guidance
Make Goods
Penny Stocks
Recent Additions
All Companies
Jinzanghuang Tibet (OTC BB:JZHG)
GeoProfile
Overview
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders
Do you represent this company?
Learn how we can help increase your exposure to investors.
Company Description
JINZANGHUANG TIBET PHARMACEUTICALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
(Unaudited)
Three Months Ended December 31,
Six Months Ended December 31,
2011
2010
2011
2010
REVENUE
Pharmaceutical products
$
-
$
-
$
-
$
26,673
Services
2,659,182
553,038
5,223,765
553,038
2,659,182
553,038
5,223,765
579,711
COST OF SALES
Pharmaceutical products
-
-
-
24,299
Services
441,349
68,872
675,181
68,872
Business and sales related tax
148,830
-
278,142
-
590,179
68,872
953,323
93,171
GROSS PROFIT
2,069,003
484,166
4,270,442
486,540
COSTS AND EXPENSES
General and Administrative Expenses
72,514
64,858
187,153
98,737
OPERATING INCOME
1,996,489
419,308
4,083,289
387,803
OTHER INCOME
6,348
-
7,402
-
INCOME BEFORE INCOME TAX
2,002,837
419,308
4,090,691
387,803
INCOME TAX
397,729
106,993
873,295
100,060
NET INCOME
1,605,108
312,315
3,217,396
287,743
LESS: NET INCOME ATTRIBUTABLE TO NON-CONTROLLING INTERESTS
74,695
15,995
157,371
14,437
NET INCOME ATTRIBUTABLE TO THE COMPANY
1,530,413
296,320
3,060,025
273,306
OTHER COMPREHENSIVE INCOME
Foreign currency translation gain, net of tax
56,457
20,011
128,076
39,938
COMPREHENSIVE INCOME
1,586,870
316,331
3,188,101
313,244
LESS: OTHER COMPREHENSIVE INCOME ATTRIBUTABLE TO NON-CONTROLLING INTERESTS
2,823
10,512
7,516
26,581
COMPREHENSIVE INCOME ATTRIBUTABLE TO THE COMPANY
$
1,584,047
$
305,819
$
3,180,585
$
286,663
Basic and diluted earnings per common share
$
0.04
$
0.01
$
0.08
$
0.01
Weighted average number of shares outstanding
40,665,063
40,665,063
40,665,063
40,665,063
The accompanying notes are an integral part of these condensed consolidated financial statements.
Last updated February 17, 2012
Post Comment
Quick Facts
Industry
Pharma